Adding Diversity to Clinical Trial Investigators and Participants

Eli Lilly has launched new initiatives, together with the Center for Drug Development and Clinical Trials at the Roswell Park Cancer Institute, to increase the diversity of patients and researchers in clinical trials.
Genetic Engineering & Biotechnology News